Targeting the protein–protein interactions (PPIs) between chaperones and their particular partner co-chaperones provides the opportunity to specifically modulate Hsp70 or Hsp90 function in neurodegenerative diseases. This evidence concerns the gene HSPA4 and neurodegenerative disease.